We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$374M
AUM Growth
-$43.6M
(-10%)
Cap. Flow
-$66M
Cap. Flow
% of AUM
-17.63%
Top 10 Holdings %
Top 10 Hldgs %
5.06%
Holding
1,045
New
320
Increased
158
Reduced
228
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MacroGenics
MGNX
|
+$1.88M |
| 2 |
OSG
Overseas Shipholding Group Inc.
OSG
|
+$1.69M |
| 3 |
CHMT
Chemtura Corporation
CHMT
|
+$1.67M |
| 4 |
INST
Instructure, Inc.
INST
|
+$1.65M |
| 5 |
RP
RealPage, Inc.
RP
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LTRPA
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
|
+$2.15M |
| 2 |
ICU Medical
ICUI
|
+$2.15M |
| 3 |
Skywest
SKYW
|
+$2.06M |
| 4 |
NAVG
Navigators Group Inc
NAVG
|
+$2.01M |
| 5 |
Insight Enterprises
NSIT
|
+$2.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.93% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Industrials | 12.56% |
| 4 | Technology | 10.41% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Amgen
AMGN
$203B
| $481K | 0.13% |
3,293
+1,024
| +45% | +$154K |
|
252
Baxter International
BAX
$11.6B
| $481K | 0.13% |
10,855
+2,649
| +32% | +$122K |
|
|
CAF
253
Morgan Stanley China A Share Fund
CAF
$334M
| $480K | 0.13% |
+28,231
| New | +$507K |
|
254
Gilead Sciences
GILD
$161B
| $479K | 0.13% |
6,694
+1,836
| +38% | +$136K |
|
255
PVH
PVH
$3.71B
| $476K | 0.13% |
5,278
+1,639
| +45% | +$172K |
|
|
MJN
256
DELISTED
Mead Johnson Nutrition Company
MJN
| $476K | 0.13% |
+6,730
| New | +$502K |
|
|
QEP
257
DELISTED
QEP RESOURCES, INC.
QEP
| $475K | 0.13% |
+25,785
| New | +$468K |
|
258
D.R. Horton
DHI
$41B
| $474K | 0.13% |
+17,338
| New | +$495K |
|
|
BEAT
259
DELISTED
BioTelemetry, Inc.
BEAT
| $473K | 0.13% |
21,180
+2,741
| +15% | +$53.6K |
|
260
PPG Industries
PPG
$25.9B
| $472K | 0.13% |
+4,982
| New | +$476K |
|
261
Xerox
XRX
$337M
| $472K | 0.13% |
20,535
+5,641
| +38% | +$140K |
|
|
FMBI
262
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $472K | 0.13% |
18,711
-6,115
| -25% | -$135K |
|
263
Booz Allen Hamilton
BAH
$8.7B
| $471K | 0.13% |
+13,054
| New | +$443K |
|
264
Zimmer Biomet
ZBH
$17.7B
| $471K | 0.13% |
+4,702
| New | +$504K |
|
265
Edgewell Personal Care
EPC
$1.27B
| $470K | 0.13% |
6,433
+1,320
| +26% | +$102K |
|
266
Hain Celestial
HAIN
$47.8M
| $470K | 0.13% |
12,043
+1,008
| +9% | +$37.8K |
|
|
IPG
267
DELISTED
Interpublic Group of Companies
IPG
| $470K | 0.13% |
+20,097
| New | +$465K |
|
268
Moody's
MCO
$81.7B
| $470K | 0.13% |
+4,990
| New | +$504K |
|
269
News Corp Class A
NWSA
$14.5B
| $470K | 0.13% |
40,987
+12,905
| +46% | +$160K |
|
270
Ashland
ASH
$3.04B
| $469K | 0.13% |
+8,767
| New | +$482K |
|
271
Strategy Inc
MSTR
$33.5B
| $469K | 0.13% |
23,760
-4,230
| -15% | -$80K |
|
272
Perrigo
PRGO
$1.4B
| $469K | 0.13% |
+5,636
| New | +$489K |
|
273
S&P Global
SPGI
$126B
| $469K | 0.13% |
+4,364
| New | +$521K |
|
274
Kinder Morgan
KMI
$73.1B
| $468K | 0.13% |
22,588
+5,199
| +30% | +$110K |
|
|
WBA
275
DELISTED
Walgreens Boots Alliance
WBA
| $468K | 0.13% |
+5,652
| New | +$467K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q4 2016 Portfolio in Review
As of Q4 2016, TFS Capital held 1,045 positions worth $374M, down 10% from $418M the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
TFS Capital withdrew a net $66M in Q4 2016, closing 333 positions and reducing 228 holdings. Its most notable exit was Liberty TripAdvisor Holdings, Inc. Series A, an estimated $2.15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, TFS Capital opened a new position in MacroGenics worth $1.53M.
- TFS Capital's largest Q4 2016 buy was MacroGenics: 74,801 shares worth $1.53M.
- TFS Capital added most to Overseas Shipholding Group Inc. in Q4 2016, an estimated $1.69M increase.
- TFS Capital's biggest Q4 2016 reduction was ICU Medical, cutting an estimated $2.15M.
- TFS Capital fully exited Liberty TripAdvisor Holdings, Inc. Series A in Q4 2016, selling an estimated $2.15M.
- TFS Capital's ten largest holdings make up 5.1% of its $374M portfolio in Q4 2016.
- TFS Capital opened 320 new positions and closed 333 in Q4 2016.
- TFS Capital's portfolio value fell 10% quarter-over-quarter to $374M.
Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.